Detail akcie Bruker Bioscien online

Business Summary: Bruker Corporation is a developer, manufacturer and distributor of high-performance scientific instruments and analytical and diagnostic. Its segments include Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI NANO, and Bruker Energy & Supercon Technologies (BEST). BSI segment designs, manufactures and distributes life science tools based on magnetic resonance technology and offers automated laboratory research. BSI CALID segment designs, manufactures and distributes life science mass spectrometry, applied spectrometry and ion mobility spectrometry solutions, analytical and process analysis instruments and solutions. BSI NANO designs, manufactures and distributes advanced x-ray instruments, atomic force microscopy instrumentation, and fluorescence optical microscopy instruments. BEST segment develops and manufactures superconducting and non-superconducting materials and devices for use in renewable energy, energy infrastructure, healthcare and energy physics research.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2025, Bruker Corp revenues increased 2% to $3.44B. Net loss applicable to common stockholders totaled $22.5M vs. income of $113.1M. Revenues reflect BSI CALID segment increase of 11% to $1.21B, Rest of Europe segment increase of 9% to $950.2M, Rest of Asia Pacific segment increase of 7% to $552.6M, Other segment increase of 6% to $269.6M. Net loss reflects BSI NANO segment loss totaling $71.8M vs. income of $2.3M.